netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 16 of 16


Details
UPD Published from Draft Mode
03/11/2023 15:40:35
(LoweryM )
UPD sitematrix Changed from 0 to
03/11/2023 10:56:01
(DavidS )
UPD isDraft Changed from N to Y
03/11/2023 10:56:01
(DavidS )
UPD FurtherInformation Changed from
03/11/2023 10:56:01
(DavidS )
UPD Guselkumab (Tremfya®) removal of MSK indication
03/11/2023 10:56:01
(DavidS )
UPD sitematrix Changed from 0 to
23/10/2023 10:55:42
(DavidS )
UPD FurtherInformation Changed from
23/10/2023 10:55:42
(DavidS )
UPD Guselkumab (Tremfya®) updated formatting
23/10/2023 10:55:42
(DavidS )
LDL Link Added : NICE TA711: Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs : https://www.nice.org.uk/guidance/ta711
21/09/2021 11:07:32
(DavidS )
UPD sitematrix Changed from 0 to
21/09/2021 11:07:09
(DavidS )
UPD FurtherInformation Changed from

  • 100mg/1mL solution for injection

  • Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

to
21/09/2021 11:07:09
(DavidS )
UPD Guselkumab (Tremfya®) NICE TA711
21/09/2021 11:07:09
(DavidS )
UPD Guselkumab (Tremfya®) updated
31/07/2018 10:24:03
(LoweryM )
LDL Link Added : NICE TA521: Guselkumab for treating moderate to severe plaque psoriasis : https://www.nice.org.uk/guidance/ta521
30/07/2018 14:57:03
(DavidS )
UPD Guselkumab (Tremfya®) updated
30/07/2018 14:56:36
(DavidS )
ADD Guselkumab (Tremfya®) added following NICE TA521
30/07/2018 14:54:06
(DavidS )

 

 

netFormulary